Trials / Completed
CompletedNCT01659736
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Hartford Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is investigating a new indication of Transcranial Magnetic Stimulation (TMS) by conducting a pilot randomized-controlled trial (RCT) comparing structural neuronavigation-directed TMS to Sham-TMS Placebo therapy for treatment of Generalized Anxiety Disorder (GAD).
Detailed description
Participants will complete structural MRI for neuronavigation. Participants will be randomly assigned to treatment condition. TMS or Sham-TMS sessions will occur daily 5 days/week for 6 weeks. Assessments will occur at pretreatment, weekly during treatment, post-treatment, and 3 month.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TMS | Treatment will entail daily (5 days/week) sessions of TMS for 6 weeks. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2012-08-08
- Last updated
- 2016-04-27
- Results posted
- 2016-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01659736. Inclusion in this directory is not an endorsement.